ClinicalTrials.gg
CompletedNCT03196999Updated Oct 7, 2026Results posted

Remotely Resolving Psychological Stress (Remote RePS)

An interventional study of Personalized Attention Bias Training and Neutral Attention Training Condition in Post Traumatic Stress Disorder, sponsored by University of California, San Francisco. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 7, 2026Results postedStudy documents posted+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
689
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco — 2 open to participants now, 2 under way, none of them phase 3. Stress Disorders, Post-Traumatic · University of California, San Francisco.

Enrollment
3rd of 14
689 · median 74
Started
2017
the only one that year
No phase
9 of 17
none open now
Registered
12th of 17
by date

Among the 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco, this one is the 3rd largest by enrollment of the 14 interventional ones that give a count, is the only one that started in 2017, is one of 9 with no phase, and was the 12th registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

2 of the 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco, or all of them as a file.
02

Study summary

The investigators have developed a mobile app called Resolving Psychological Stress (REPS) for people with posttraumatic stress disorder (PTSD). The app will administer threat-related attention bias modification to individuals who score high on a PTSD checklist. This study will be administered remotely to individuals in the United States. The aims of the study are to explore feasibility, acceptability and usability of the app in an entirely remote study, as well as to explore the efficacy of the app at reducing attention bias and PTSD symptom severity.

Read the detailed description

Posttraumatic stress disorder (PTSD) is a highly disabling disorder that affects approximately 8% of the population worldwide. Threat-related attention biases represent an important mechanism that may underlie PTSD symptoms. Such attention biases predict risk for PTSD following trauma exposure, and are thought to maintain some symptoms of PTSD. Research indicates that specific forms of computerized attention bias modification (ABM) training are effective in reducing attention bias for threat. We have developed a mobile app called REPS (Resolving Psychological Stress) to administer threat-related ABM training to people with symptoms of PTSD and have tested it in a laboratory-based pilot study of 22 people with elevated PTSD symptoms. Our preliminary data indicate that the app is highly acceptable to patients and that use of the app reduces attention bias for threat and PTSD symptom severity. The proposed study will expand on this prior lab-based study to test ABM training on an app entirely remotely. Our primary aim is to examine the feasibility, acceptability and usability of remotely administered app-based ABM training and to determine the efficacy of remote app-based ABM training in reducing attention bias and PTSD symptom severity. Our secondary aim is to examine whether a personalized version of ABM training results in greater attentional bias change and anxiety reduction compared to a non-personalized ABM training.

03

Conditions studied

  • Post Traumatic Stress Disorder

Keywords

  • PTSD
  • Attention bias modification
  • Remote app-based study
  • Digital Health
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must own an iOS device compatible with the app (i.e. iPhones or iPod Touches)
  • Must score at or above 33 on PTSD Checklist (PCL-5), which indicates PTSD symptoms.

Exclusion criteria

Exclusion Criteria:

  • Active suicidal ideation.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
689 participants (actual)

Study arms

  • Active comparator
    Personalized Attention Bias Training

    Personalized version of ABM Training.

    Device: Personalized Attention Bias Training

  • Placebo comparator
    Neutral Attention Training Condition

    Non-active version of ABM training.

    Device: Neutral Attention Training Condition

  • Active comparator
    Non-Personalized Attention Bias Training

    Non-personalized version of ABM training.

    Device: Non-Personalized Attention Bias Training

Interventions

  • DevicePersonalized Attention Bias Training

    This self-help program will aim to reduce neurobiological threat sensitivity with the ultimate goal of developing a low-cost and highly scalable self-help tool to alleviate symptoms of PTSD. The app can be used on an iOS compatible phone and involves a training program that aims to directly reduce threat sensitivity by modifying attention. The contents of the app will be personalized for each user.

  • DeviceNeutral Attention Training Condition

    This self-help program is a placebo control program that will be used on an iOS compatible phone. The placebo will contain only neutral words.

  • DeviceNon-Personalized Attention Bias Training

    This self-help program administered on an app will aim to reduce neurobiological threat sensitivity with the ultimate goal of a low-cost and highly scalable self-help tool to alleviate symptoms of PTSD. The app can be used on an iOS compatible phone and involves a training program that aims to directly reduce threat sensitivity by modifying attention. The contents of the app will be the same for each user.

06

What researchers measure

Primary outcomes

  1. Change in PTSD Checklist for DSM-5 (PCL-5) Score (Before/After Training)

    Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between baseline (Day 1) and post-training (Day 14) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.

    Time frame: 2 weeks

  2. Change in PTSD Checklist for DSM-5 (PCL-5) Scores (Follow-Up)

    Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between post-training (Day 14) and follow-up (Day 56) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.

    Time frame: 6 weeks.

07

Results

Posted Oct 7, 2026

Participant flow

Participant flow — Overall Study
MilestonePersonalized Attention Bias TrainingNeutral Attention Training ConditionNon-Personalized Attention Bias Training
Started234236219
Completed147151140
Not completed878579

Outcome measures

PrimaryChange in PTSD Checklist for DSM-5 (PCL-5) Score (Before/After Training)

Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between baseline (Day 1) and post-training (Day 14) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.

Time frame:
2 weeks
Reported as:
Mean · Scores on a scale
Change in PTSD Checklist for DSM-5 (PCL-5) Score (Before/After Training)
Scores on a scalePersonalized Attention Bias TrainingNeutral Attention Training ConditionNon-Personalized Attention Bias Training
Change in PTSD Checklist for DSM-5 (PCL-5) Score (Before/After Training)-8.67 ± 15.46-7.97 ± 14.93-10.41 ± 16.39
PrimaryChange in PTSD Checklist for DSM-5 (PCL-5) Scores (Follow-Up)

Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between post-training (Day 14) and follow-up (Day 56) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.

Time frame:
6 weeks.
Reported as:
Mean · Scores on a scale
Change in PTSD Checklist for DSM-5 (PCL-5) Scores (Follow-Up)
Scores on a scalePersonalized Attention Bias TrainingNeutral Attention Training ConditionNon-Personalized Attention Bias Training
Change in PTSD Checklist for DSM-5 (PCL-5) Scores (Follow-Up)0.27 ± 15.860.05 ± 13.33-0.28 ± 14.09

Adverse events

Collected over From baseline assessment until the end of follow-up, approximately 6 weeks.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Personalized Attention Bias Training0/234 (0%)0/234 (0%)0/234 (0%)
Neutral Attention Training Condition0/236 (0%)0/236 (0%)0/236 (0%)
Non-Personalized Attention Bias Training0/219 (0%)0/219 (0%)0/219 (0%)

Baseline characteristics

Baseline characteristics were reported for all participants enrolled in the study who completed measures at Day 1 of training.

Age, Continuous
Age, Continuous(Years)Personalized Attention Bias Modification TrainingNeutral Attention Bias Modification TrainingNon-Personalized Attention Bias Modification TrainingTotal
Mean32.0 ± 10.032.0 ± 9.5932.2 ± 10.132.1 ± 9.87
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Personalized Attention Bias Modification TrainingNeutral Attention Bias Modification TrainingNon-Personalized Attention Bias Modification TrainingTotal
Sex — Male455041136
Sex — Female188186177551
Sex — Missing1012
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Personalized Attention Bias Modification TrainingNeutral Attention Bias Modification TrainingNon-Personalized Attention Bias Modification TrainingTotal
Race/Ethnicity — African American/Black25283285
Race/Ethnicity — American Indian/Alaskan0123
Race/Ethnicity — Asian21162057
Race/Ethnicity — Caucasian/European American138141120399
Race/Ethnicity — Hawaiian/Pacific Islander1001
Race/Ethnicity — Hispanic/Latino28342789
Race/Ethnicity — More than 1 ethnicity19151751
Race/Ethnicity — Other1113
Race/Ethnicity — Missing1001
08

Study locations

1 site
  • University of California, San Francisco
    San Francisco, California 94143, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2017 to primary completion in Nov 2018, 11 months.

Results were first posted in Oct 2026, 7 years 11 months after primary completion.

Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 11 months is below that.

Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 20, 2017
First posted
Jun 23, 2017
StartActual
Nov 30, 2017
Primary completionActual
Nov 1, 2018
CompletionActual
Nov 1, 2018
Results first posted
Oct 7, 2026
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 7, 2026
Enrollment
528→689
Oct 7, 2026
Interventions
Added Device: Personalized Attention Bias Training·Device: Neutral Attention Training Condition·Device: Non-Personalized Attention Bias Training; removed Behavioral: Personalized Attention Bias Training·Behavioral: Neutral Attention Training Condition·Behavioral: Non-Personalized Attention Bias Training
Oct 7, 2026
Primary outcomes
2 added, 2 removed
What changed in the outcomes
  • AddedChange in PTSD Checklist for DSM-5 (PCL-5) Score (Before/After Training)Time frame: 2 weeks
  • AddedChange in PTSD Checklist for DSM-5 (PCL-5) Scores (Follow-Up)Time frame: 6 weeks.
  • RemovedAcceptability, feasibility and usability of completing attention bias modification via a mobile app.Time frame: Two weeks
  • RemovedReduction in post traumatic stress disorder (PTSD) symptomsTime frame: Two weeks
Oct 7, 2026
Documents
Secondary outcomes
1 removed
What changed in the outcomes
  • RemovedReduction of PTSD Checklist (PCL) score with personalized attention bias modificationTime frame: Two weeks
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Results posted
    Enrollment 528→689
    Primary outcomes 2 added, 2 removed
    What changed in the outcomes
    • AddedChange in PTSD Checklist for DSM-5 (PCL-5) Score (Before/After Training)Time frame: 2 weeks
    • AddedChange in PTSD Checklist for DSM-5 (PCL-5) Scores (Follow-Up)Time frame: 6 weeks.
    • RemovedAcceptability, feasibility and usability of completing attention bias modification via a mobile app.Time frame: Two weeks
    • RemovedReduction in post traumatic stress disorder (PTSD) symptomsTime frame: Two weeks
    Secondary outcomes 1 removed
    What changed in the outcomes
    • RemovedReduction of PTSD Checklist (PCL) score with personalized attention bias modificationTime frame: Two weeks
    Interventions Added Device: Personalized Attention Bias Training·Device: Neutral Attention Training Condition·Device: Non-Personalized Attention Bias Training; removed Behavioral: Personalized Attention Bias Training·Behavioral: Neutral Attention Training Condition·Behavioral: Non-Personalized Attention Bias Training
    + 4 other changes: index terms, verification date, oversight details and data sharing statement

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT03196999
Responsible party
Sponsor
First posted
Jun 23, 2017
Start date
Nov 30, 2017
Primary completion
Nov 1, 2018
Completion
Nov 1, 2018
Results posted
Oct 7, 2026
Last update
Oct 7, 2026

Study contacts

Aoife S O'Donovan, Ph.D.
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion